Table 3. Availability of the recommended drugs for community case management in Countdown priority countries from which data were collected, 2009–2010.
| Availability | No. of malaria-endemic countries (n = 53) |
No. of responding countries (n = 59) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACT | Mon | ORS + Zn | ORS | CTX | Amox | Cef | Amp | Gen | Pen | ||
| First-line treatment | 38 | 5 | 40 | 54 | 35 | 21 | 1 | 10 | 16 | 10 | |
| Essential drug list | 43 | 13 | 36 | 54 | 42 | 41 | 9 | 30 | 34 | 30 | |
| Over the counter | 26 | 16 | 16 | 49 | 25 | 29 | 12 | 18 | 17 | 18 | |
| Private sector | 38 | 24 | 22 | 49 | 41 | 43 | 30 | 33 | 33 | 32 | |
| CCM programme | 41 | 10 | 17 | 50 | 28 | 13 | 0 | 2 | 2 | 2 | |
ACT, artemisinin-based combination therapies; Amox, amoxicillin; Amp, ampicillin; CCM, community case management; Cef, cefuroxime; CTX, cotrimoxazole; Gen, gentamicin; Mon, monotherapies; ORS: oral rehydration salts; Pen, penicillin; Zn, zinc.